Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

BACKGROUND: Pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) are at high risk of acquiring fungal infections. Antifungal prophylaxis shortly after transplantation is therefore indicated, but data for pediatric patients under 12 years of age are scarce. To address this iss...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Döring, Michaela, Müller, Carsten, Johann, Pascal-David, Erbacher, Annika, Kimmig, Astrid, Schwarze, Carl-Philipp, Lang, Peter, Handgretinger, Rupert, Müller, Ingo
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3514296/
https://ncbi.nlm.nih.gov/pubmed/23082876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-12-263
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars